About Shenqi Medical
Shenqi Medical is a company based in Pudong (China) founded in 2014 by Dai Zhihao. Shenqi Medical has raised $14.44 million across 1 funding round from investors including Hillhouse, LYFE Capital and 3H Health Investment. Shenqi Medical operates in a competitive market with competitors including Cardiovascular Systems, Contego Medical, AngioScore, Echopoint Medical and Shape Memory Medical, among others.
- Headquarter Pudong, China
- Founders Dai Zhihao
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$14.44 M (USD)
in 1 rounds
-
Latest Funding Round
$14.44 M (USD), Series C
Aug 24, 2020
-
Investors
Hillhouse
& 3 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Shenqi Medical
Shenqi Medical has successfully raised a total of $14.44M through 1 strategic funding round. The most recent funding activity was a Series C round of $14.44 million completed in August 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Shenqi Medical
Shenqi Medical has secured backing from 4 investors, including venture fund investors. Prominent investors backing the company include Hillhouse, LYFE Capital and 3H Health Investment.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Global private equity investments are managed with long-term focus.
|
Locked | Locked | Locked | |
|
LYFE Capital is recognized as a premier healthcare investment platform.
|
Locked | Locked | Locked | |
|
Investment in health innovation and therapies is facilitated.
|
Locked | Locked | Locked |
Investor details for Shenqi Medical
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Shenqi Medical
Investment portfolio details for Shenqi Medical
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Shenqi Medical
Detailed financials for Shenqi Medical
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Shenqi Medical Comparisons
Peer comparison for Shenqi Medical
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Shenqi Medical
Shenqi Medical operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Cardiovascular Systems, Contego Medical, AngioScore, Echopoint Medical and Shape Memory Medical, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Devices for treating peripheral and coronary vascular disease are developed.
|
|
| Locked | Locked | Locked |
Provider of vascular stenting with embolic protection for both coronary and peripheral vasculature
|
|
| Locked | Locked | Locked |
Scoring balloon catheters for coronary and peripheral angioplasty are developed.
|
|
| Locked | Locked | Locked |
Smart devices for monitoring coronary artery disease are developed.
|
|
| Locked | Locked | Locked |
Embolization devices are developed using Shape Memory Polymer foams.
|
|
| Locked | Locked | Locked |
Developer a system for venous arterialization of the lower limbs
|
Detailed competitors of Shenqi Medical
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Shenqi Medical
Complete news archive for Shenqi Medical
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Shenqi Medical
Shenqi Medical was founded in 2014 and raised its 1st funding round 6 years after it was founded.
Shenqi Medical is headquartered in Pudong, China. It is registered at Pudong, Shanghai, China.
Shenqi Medical is a funded company, having raised a total of $14.44M across 1 funding round to date.
Developer of a medical device for cardiovascular surgeries. It offers a Swide Qiji drug-coated coronary balloon catheter and SQ-Kyrin Shen Qiqilin transcatheter mitral valve clip and steerable guide catheter for heart failure ultrafiltration treatment.
Shenqi Medical's top competitors include Contego Medical, Limflow and Shape Memory Medical.
Shenqi Medical has 4 investors. Key investors include Hillhouse, LYFE Capital, 3H Health Investment, and Apricot Capital.